Merial
3239 Satellite Boulevard
Building 500
Duluth
Georgia
30096
United States
Tel: 678-638-3000
Website: http://www.merial.com/
35 articles about Merial
-
Boehringer Ingelheim To Donate 75,000 Doses Of Rabies Vaccine To The Global Alliance For Rabies Control Through Shots For Good Initiative
9/12/2018
In recognition of World Rabies Day on September 28, this significant rabies vaccine donation will support GARC's efforts to address deaths due to rabies in Madagascar.
-
FDA approves NexGard® (afoxolaner) for the prevention of infections that cause Lyme disease in dogs
8/27/2018
First, and only, flea and tick product approved by the FDA to prevent Borrelia burgdorferi infections in dogs by killing black-legged ticks.
-
Merial, Now Part of Boehringer Ingelheim, Grows Canine Vaccine Portfolio With Introduction of RECOMBITEK Oral Bordetella
2/5/2018
RECOMBITEK vaccines are manufactured by Merial. Merial is now a part of Boehringer Ingelheim.
-
Merial Hires Three Veterinary Professionals; Expands Animal Health Technical Support Team
8/5/2016
-
Merial Launches Combination Vaccine To Help Prevent Core Canine Diseases And Provide Comprehensive Leptospirosis Protection
4/27/2016
-
Merial Appoints Susan Sholtis As President, North America
2/1/2016
-
Merial Collaborates With Georgia Institute of Technology To Bring Animal Health Information To Connected Devices
1/28/2016
-
Phibro Animal Health Corporation Announces Licensing Agreement With Merial For Phibro's Vaccine Delivery Technology
1/27/2015
-
Merial Announces New Claims For Nexgard (Afoxolaner): Now Approved To Kill Two Additional Species Of Ticks
5/19/2014
-
Global Green Announces Extension Of Agreement With Merial For Evaluation Of Salmonella Vaccine And License Option
5/7/2014
-
Imaxio Signs an Option for a Licence Agreement With Merial to Develop an Animal Health Vaccine
12/13/2012
-
Merial Launches "Outbreak Alert" Program
6/1/2011
-
GenVec Inc. Expands Collaboration With Merial
5/3/2011
-
GenVault Corporation Forms Collaboration With World-Leading Animal Health Company, Merial to Commercialize Foot and Mouth Vaccine
12/30/2010
-
Biolex Therapeutics and Merial Broaden Collaboration
7/15/2010
-
Infectious Disease Research Institute (IDRI) and Merial Enter into Research Collaboration
7/14/2010
-
Bioject Medical Technologies Inc. Meets Final Development Milestone for Merial
4/7/2010
-
SCYNEXIS, Inc. Receives Merial Research Collaboration Milestone Payment
11/4/2009
-
Merial Invests $70 Million in Nanchang, China
10/12/2009
-
Sanofi-Aventis (France) Completes Merial (JOBS) Stake Buy from Merck & Co., Inc. (JOBS) for $4.0 Billion
9/18/2009